E&G Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-291
| Closed | -$207K | – | 215 |
|
|
2024
Q4 | $207K | Sell |
291
-10
| -3% | -$7.12K | 0.06% | 201 |
|
|
2024
Q3 | $316K | Hold |
301
| – | – | 0.09% | 163 |
|
|
2024
Q2 | $316K | Hold |
301
| – | – | 0.09% | 158 |
|
|
2024
Q1 | $290K | Hold |
301
| – | – | 0.09% | 156 |
|
|
2023
Q4 | $264K | Sell |
301
-4
| -1% | -$3.51K | 0.09% | 164 |
|
|
2023
Q3 | $251K | Hold |
305
| – | – | 0.09% | 172 |
|
|
2023
Q2 | $219K | Hold |
305
| – | – | 0.08% | 184 |
|
|
2023
Q1 | $251K | Sell |
305
-5
| -2% | -$4.11K | 0.09% | 174 |
|
|
2022
Q4 | $224K | Hold |
310
| – | – | 0.08% | 184 |
|
|
2022
Q3 | $214K | Buy |
+310
| New | +$214K | 0.08% | 190 |
|
|
2022
Q2 | – | Sell |
-310
| Closed | -$217K | – | 216 |
|
|
2022
Q1 | $217K | Buy |
+310
| New | +$217K | 0.06% | 205 |
|
|
2021
Q3 | – | Hold |
0
| – | -$235K | – | 209 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 191 |
|